Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.
<h4>Objective</h4>To compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia.<h4>Methods</h4><h4>Population</h4>adult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prol...
Saved in:
Main Authors: | Xianbin Li, Yilang Tang, Chuanyue Wang |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/4cfa137a5aca45f79cbcbad31f0db9ab |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
by: Ranjbar F, et al.
Published: (2015) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
by: Luan SX, et al.
Published: (2018) -
Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
by: Somaieh Ashrafi, et al.
Published: (2022) -
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
by: Ishioka M, et al.
Published: (2015) -
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
by: Izchak Kohen, et al.
Published: (2010)